$Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.$

Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.

Urothelial carcinoma (UC) accounts for 5% to 10% of malignancies in men in Europe and the United States. For locally advanced or metastatic disease, there are two standard firstline chemotherapy regimens: MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) and gemcitabine/cisplatin. For refract...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Morel, A, Talbot, D
Format:	Journal article
Język:	English
Wydane:	Dove Medical Press Ltd. 2010

Podobne zapisy

Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use
od: A. A. Gritskevich, i wsp.
Wydane: (2022-06-01)

From clinical trials to the front line: Vinflunine for Treatment of UrothelialCell Carcinoma at the National Cancer Institute of Naples
od: GAETANO eFACCHINI, i wsp.
Wydane: (2016-05-01)

Vinflunine in the treatment of bladder cancer
od: Mark Bachner, i wsp.
Wydane: (2008-11-01)

A Prospective Study of I.V. Vinflunine in the Treatment of Patients with Advanced or Metastatic Urothelial Carcinoma after Failure of a Platinum-containing Regimen and Biomarker Correlates
od: Fatma M.A. Abouelkasem, i wsp.
Wydane: (2022-08-01)

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)
od: Rodolfo Passalacqua, i wsp.
Wydane: (2017-07-01)

Phase II study of vinflunine in malignant pleural mesothelioma.
od: Talbot, D, i wsp.
Wydane: (2007)

Stathmin potentiates vinflunine and inhibits Paclitaxel activity.
od: Soazig Malesinski, i wsp.
Wydane: (2015-01-01)

Update on the Treatment of Metastatic Urothelial Carcinoma
od: Nedal Bukhari, i wsp.
Wydane: (2018-01-01)

Metastatic urothelial carcinoma
od: Elisabeth Gómez-Moyano, i wsp.
Wydane: (2021-08-01)

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, <it>in vitro</it>
od: Pattyn Greet GO, i wsp.
Wydane: (2008-02-01)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
od: Inokuchi J, i wsp.
Wydane: (2019-05-01)

Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma
od: Ray Manneh Kopp, i wsp.
Wydane: (2024-01-01)

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
od: Tassinari E, i wsp.
Wydane: (2022-06-01)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
od: Nobutaka Nishimura, i wsp.
Wydane: (2022-09-01)

Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients
od: Avery Braun, i wsp.
Wydane: (2025-02-01)

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
od: Keren Rouvinov, i wsp.
Wydane: (2023-05-01)

Denosumab for the Treatment of Refractory Hypercalcemia in Metastatic Parathyroid Carcinoma
od: Saori Itoshima, MD, i wsp.
Wydane: (2015-01-01)

Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma
od: Andrey Soares, i wsp.
Wydane: (2020-01-01)

Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
od: Gaetano Pezzicoli, i wsp.
Wydane: (2024-03-01)

Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
od: Brigida Anna Maiorano, i wsp.
Wydane: (2023-09-01)

Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma
od: Kazuki Yanagida, i wsp.
Wydane: (2024-07-01)

Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary Referral Center in Portugal
od: Vasco Quaresma, i wsp.
Wydane: (2023-02-01)

Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma
od: Christina D. Enescu, BS, i wsp.
Wydane: (2022-03-01)

Concordance of plasmatic circulating DNA and matched metastatic tissue in metastatic urothelial carcinoma
od: I. Duquesne, i wsp.
Wydane: (2020-07-01)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
od: Noah Frydenlund MS, i wsp.
Wydane: (2018-10-01)

Metastatic anal cloacogenic cell carcinoma misdiagnosed as urothelial carcinoma with long survival
od: Burak Bilgin, i wsp.
Wydane: (2017-07-01)

Treatment Patterns for Metastatic Urothelial Carcinoma Across Eight Mexican Centers: The ALEBRIJE Study
od: Evelyn Lilian Beas-Lozano, i wsp.
Wydane: (2025-01-01)

A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinoma
od: Yousuke Fukiishi, i wsp.
Wydane: (2023-03-01)

Metastatic urothelial carcinoma in multiple appendicular muscles of a cat
od: Eduardo M Hernández, i wsp.
Wydane: (2025-01-01)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
od: Zhiying Shao, i wsp.
Wydane: (2016-10-01)

Unusual Duodenal Ulcer: Metastatic Urothelial Carcinoma of the Renal Pelvis
od: Yoo Dong Won, i wsp.
Wydane: (2023-07-01)

Cutaneous metastatic implantation of ureteric urothelial carcinoma to the glans and prepuce
od: G.N. Weeratunga
Wydane: (2023-03-01)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
od: Siteng Chen, i wsp.
Wydane: (2020-08-01)

Progress in immune checkpoint inhibitor-based combined regimens in the treatment of metastatic urothelial carcinoma
od: Liu Jianbing, Yue Zhongjin, Shang Panfeng, Liu Yating, Chang Hong
Wydane: (2023-09-01)

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma
od: Ping Hu, i wsp.
Wydane: (2024-03-01)

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion
od: Tämer El Saadany, i wsp.
Wydane: (2024-08-01)

Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic to the Stomach: A Case Report
od: Philippe Nabbout, i wsp.
Wydane: (2012-01-01)

Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia
od: Robert C. Chan, i wsp.
Wydane: (2007-01-01)

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
od: Marco Audisio, i wsp.
Wydane: (2022-05-01)

Real-life data of Atezolizumab in urothelial carcinoma, second-line metastatic disease
od: L.F. Sánchez-Cousido, i wsp.
Wydane: (2020-11-01)